Transdermal Drug Delivery Systems Market Demand, Trends and Business Opportunities 2022-2027

1
Global Transdermal Drug Delivery Systems Market
Research and Forecast Report 2022-2027




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Transdermal Drug Delivery Systems Market
Research Report The latest report by IMARC,
titled Transdermal Drug Delivery Systems Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2022-2027 " the global
transdermal drug delivery systems market reached
a value of US 6.0 Billion in 2021. Transdermal
drug delivery (TDD) systems include the
utilization of non-invasive methods for drug
administration. In this method, the drug is
penetrated via the stratum corneum, which is then
passed through the dermis and the epidermis layer
of the skin. In comparison with the conventional
oral intravascular and parenteral route mode of
drug delivery, these methods do not damage the
skin layers or other tissues while improving the
efficacy of the dosage. As a result, they are
extensively utilized in the treatment of acute
and chronic diseases as well as in cosmetic
procedures. Request Free Sample Report
https//www.imarcgroup.com/transdermal-drug-delive
ry-systems-market/requestsample
4
Report Description and Highlights
Report Description

Global Transdermal Drug Delivery Systems Market
Trends The global market is primarily driven
by the increasing preference for
self-administered modes of drug delivery. Coupled
with the rising demand for non-invasive treatment
methods among the masses, this is providing a
boost to the market growth. Also, the rising
preference for maintaining an aesthetic
appearance among individuals has led to
escalating demand for cosmetic surgeries, which
is favorably impacting the market growth. Along
with this, the increasing geriatric population
and the rising prevalence of acute illnesses
among individuals are creating a positive outlook
for the market on the global level. Moreover,
various technological advancements in the market,
including the introduction of dissolving
microneedles and sonophoresis techniques, are
creating a positive outlook for the market. Other
factors, including increasing healthcare
expenditure, continuous improvements in the
healthcare infrastructure and extensive research
and development (RD) activities conducted by key
players to introduce innovative product variants
with improved quality, are further contributing
to the market growth. On account of the
aforementioned factors, the market is anticipated
to grow at a CAGR of 6.36 during
2022-2027. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2022-2027).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Technology
Electroporation Radiofrequency
Iontophoresis Microporation
Thermal Mechanical Arrays Ultr
asound Others Breakup by Application
Central Nervous System
Pain Management Cardiovascular
Hormone Others

6
Report Description and Highlights
Report Description
Breakup by Region North America
United States Canada
Asia-Pacific China
Japan India
South Korea Austral
ia Indonesia O
thers Europe Germany
France United K
ingdom Italy S
pain Russia Ot
hers

7
Report Description and Highlights
Report Description
Latin America Brazil
Mexico Others
Middle East and Africa
Note We are updating our reports, If you want
latest primary and secondary data (2022-2027)
with Cost Module, Business Strategy, Distribution
Channel, etc. Click request free sample report.

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Acrux Limited Boehringer Ingelheim International G
  mbH Hisamitsu Pharmaceutical Co. Inc. Lavipharm S.
  A. LEAD CHEMICAL Co. Ltd. Luye Pharma Group Nutrib
  and Inc. Viatris Inc.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/transdermal-drug-delive
  ry-systems-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us